Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

BACKGROUND: Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy in this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Res Pract
Autors principals: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Tünnerhoff, Johannes, Mengel, Annerose, Kuhn, Joachim, Ziemann, Ulf, Poli, Sven
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919064/
https://ncbi.nlm.nih.gov/pubmed/33641678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-021-00105-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars